Edesa Biotech, Inc. 8-K

What Happened

• Edesa Biotech, Inc. (EDSA) filed Form 8-K on May 29, 2026 reporting results of its May 27, 2026 Annual General and Special Meeting. Shareholders approved an amendment to the company’s 2019 Equity Incentive Compensation Plan to add 750,000 shares and to eliminate the plan’s annual per‑participant option grant limit (Amendment No. 5, filed as Exhibit 10.1).
• Shareholders re-elected the full slate of directors — Joan Chypyha, David Liu, Sean MacDonald, Patrick Marshall, Pardeep Nijhawan, Charles Olson and Carlo Sistilli — and approved the advisory vote on executive compensation. Shareholders also appointed MNP LLP as the company’s auditors for the fiscal year ending September 30, 2026. Approximately 4,901,921 common shares (about 55% of outstanding shares entitled to vote) were represented.

Key Details

• Meeting date/filed: Annual Meeting held May 27, 2026; Form 8-K filed May 29, 2026.
• Equity plan change: increase of 750,000 shares available under the 2019 Equity Incentive Compensation Plan and elimination of the annual per‑participant option grant limit (Amendment No. 5, Exhibit 10.1).
• Voting turnout and results highlights:
  • Shares represented: 4,901,921 (~55% of outstanding voting shares).
  • Proposal to amend equity plan: For 2,613,551; Against 130,589; Abstain 10,680; Broker Non‑Votes 2,147,101.
  • Advisory vote on executive compensation: For 2,670,075; Against 69,281; Abstain 15,464; Broker Non‑Votes 2,147,101.
  • Auditor appointment (MNP LLP): For 4,814,478; Withhold 87,443.

Why It Matters

• The equity plan increase and removal of the per‑participant grant cap create additional capacity for stock-based compensation, which can dilute existing shareholders if granted and exercised. Investors should note the added 750,000-share pool as a potential source of future dilution.
• Re-election of the full board and approval of executive pay (advisory) indicate shareholder support for current governance and management. The appointment of MNP LLP establishes the company’s auditor for the coming fiscal year.
• The Plan Amendment is filed as Exhibit 10.1 to the 8-K for investors who want the full terms and language of the change.